| Dr Katherine Marie Shea, MD | |
|
300 Pasteur Dr., Stanford Hospital And Clinics, Stanford, CA 94305-2200 | |
| (650) 723-9215 | |
| Not Available |
| Full Name | Dr Katherine Marie Shea |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 300 Pasteur Dr., Stanford, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609160902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A122226 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Oregon Emergency Physicians Llc | 6406926211 | 27 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
The U.S. Food and Drug Administration (FDA) has announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
The World Bank on Wednesday announced that its International Development Association (IDA) fund will receive $49.3 billion over the next three years, Bloomberg reports (Christie/Martens, 12/15).
Phylonix Pharmaceuticals announced, at the Society of Toxicology Annual Meeting in Baltimore, that the U.S. Patent and Trademark Office has issued the company a broad patent for assessing the toxicity of pharmaceutical test agents on cardiovascular functions in zebrafish.
› Verified 2 days ago
| Entity Name | Central Oregon Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376714543 PECOS PAC ID: 6406926211 Enrollment ID: O20080605000639 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
The U.S. Food and Drug Administration (FDA) has announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
The World Bank on Wednesday announced that its International Development Association (IDA) fund will receive $49.3 billion over the next three years, Bloomberg reports (Christie/Martens, 12/15).
Phylonix Pharmaceuticals announced, at the Society of Toxicology Annual Meeting in Baltimore, that the U.S. Patent and Trademark Office has issued the company a broad patent for assessing the toxicity of pharmaceutical test agents on cardiovascular functions in zebrafish.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine Marie Shea, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (415) 516-7896 | Dr Katherine Marie Shea, MD 300 Pasteur Dr., Stanford Hospital And Clinics, Stanford, CA 94305-2200 Ph: (650) 723-9215 |
News Archive
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
The U.S. Food and Drug Administration (FDA) has announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
The World Bank on Wednesday announced that its International Development Association (IDA) fund will receive $49.3 billion over the next three years, Bloomberg reports (Christie/Martens, 12/15).
Phylonix Pharmaceuticals announced, at the Society of Toxicology Annual Meeting in Baltimore, that the U.S. Patent and Trademark Office has issued the company a broad patent for assessing the toxicity of pharmaceutical test agents on cardiovascular functions in zebrafish.
› Verified 2 days ago
Enoch Akuffo Obeng, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Timothy John Batchelor, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Swaminatha V Mahadevan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Kelly Nicole Roszczynialski, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Graham Walker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Mc: 5500, Stanford, CA 94305 Phone: 650-723-4000 | |
Shawn Keiji Kaku, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Joseph Urban Becker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 |